Implementing a treatment plan that includes ganglionic blocking drugs and vasodilators could lead to a drug interaction that could result in:
a. additive anticholinegic effects
b. additive antiadrenergic effects
c. antagonism of anticholinerigc effects
d. additive vasodilation effects